IBDEI0C9 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5822,1,5,0)
 ;;=5^252.02
 ;;^UTILITY(U,$J,358.3,5822,2)
 ;;=^331440
 ;;^UTILITY(U,$J,358.3,5823,0)
 ;;=794.6^^49^522^1
 ;;^UTILITY(U,$J,358.3,5823,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5823,1,4,0)
 ;;=4^ABN ENDOCRINE STUDY NEC
 ;;^UTILITY(U,$J,358.3,5823,1,5,0)
 ;;=5^794.6
 ;;^UTILITY(U,$J,358.3,5823,2)
 ;;=^273448
 ;;^UTILITY(U,$J,358.3,5824,0)
 ;;=783.1^^49^522^2
 ;;^UTILITY(U,$J,358.3,5824,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5824,1,4,0)
 ;;=4^ABNORMAL WEIGHT GAIN
 ;;^UTILITY(U,$J,358.3,5824,1,5,0)
 ;;=5^783.1
 ;;^UTILITY(U,$J,358.3,5824,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,5825,0)
 ;;=780.53^^49^522^15
 ;;^UTILITY(U,$J,358.3,5825,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5825,1,4,0)
 ;;=4^SLEEP APNEA W/ HYPERSOMNIA
 ;;^UTILITY(U,$J,358.3,5825,1,5,0)
 ;;=5^780.53
 ;;^UTILITY(U,$J,358.3,5825,2)
 ;;=^332925
 ;;^UTILITY(U,$J,358.3,5826,0)
 ;;=780.57^^49^522^14
 ;;^UTILITY(U,$J,358.3,5826,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5826,1,4,0)
 ;;=4^SLEEP APNEA W/ DISTURB
 ;;^UTILITY(U,$J,358.3,5826,1,5,0)
 ;;=5^780.57
 ;;^UTILITY(U,$J,358.3,5826,2)
 ;;=^332928
 ;;^UTILITY(U,$J,358.3,5827,0)
 ;;=259.2^^49^522^4
 ;;^UTILITY(U,$J,358.3,5827,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5827,1,4,0)
 ;;=4^CARCINOID SYNDROME
 ;;^UTILITY(U,$J,358.3,5827,1,5,0)
 ;;=5^259.2
 ;;^UTILITY(U,$J,358.3,5827,2)
 ;;=^19261
 ;;^UTILITY(U,$J,358.3,5828,0)
 ;;=428.0^^49^522^5
 ;;^UTILITY(U,$J,358.3,5828,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5828,1,4,0)
 ;;=4^CONGESTIVE HEART FAILURE
 ;;^UTILITY(U,$J,358.3,5828,1,5,0)
 ;;=5^428.0
 ;;^UTILITY(U,$J,358.3,5828,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,5829,0)
 ;;=414.00^^49^522^3
 ;;^UTILITY(U,$J,358.3,5829,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5829,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,5829,1,5,0)
 ;;=5^414.00
 ;;^UTILITY(U,$J,358.3,5829,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,5830,0)
 ;;=401.9^^49^522^7
 ;;^UTILITY(U,$J,358.3,5830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5830,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,5830,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,5830,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,5831,0)
 ;;=259.9^^49^522^6
 ;;^UTILITY(U,$J,358.3,5831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5831,1,4,0)
 ;;=4^ENDOCRINE DISORDER NOS
 ;;^UTILITY(U,$J,358.3,5831,1,5,0)
 ;;=5^259.9
 ;;^UTILITY(U,$J,358.3,5831,2)
 ;;=^267898
 ;;^UTILITY(U,$J,358.3,5832,0)
 ;;=251.1^^49^522^9
 ;;^UTILITY(U,$J,358.3,5832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5832,1,4,0)
 ;;=4^INSULINOMA
 ;;^UTILITY(U,$J,358.3,5832,1,5,0)
 ;;=5^251.1
 ;;^UTILITY(U,$J,358.3,5832,2)
 ;;=^87642
 ;;^UTILITY(U,$J,358.3,5833,0)
 ;;=278.00^^49^522^11
 ;;^UTILITY(U,$J,358.3,5833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5833,1,4,0)
 ;;=4^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,5833,1,5,0)
 ;;=5^278.00
 ;;^UTILITY(U,$J,358.3,5833,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,5834,0)
 ;;=278.01^^49^522^10
 ;;^UTILITY(U,$J,358.3,5834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5834,1,4,0)
 ;;=4^MORBID OBESITY
 ;;^UTILITY(U,$J,358.3,5834,1,5,0)
 ;;=5^278.01
 ;;^UTILITY(U,$J,358.3,5834,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,5835,0)
 ;;=251.2^^49^522^13
 ;;^UTILITY(U,$J,358.3,5835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5835,1,4,0)
 ;;=4^REACTIVE HYPOGLYCEMIA NOS
 ;;^UTILITY(U,$J,358.3,5835,1,5,0)
 ;;=5^251.2
 ;;^UTILITY(U,$J,358.3,5835,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,5836,0)
 ;;=327.23^^49^522^12
 ;;^UTILITY(U,$J,358.3,5836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5836,1,4,0)
 ;;=4^OBSTRUCTIVE SLEEP APNEA
 ;;^UTILITY(U,$J,358.3,5836,1,5,0)
 ;;=5^327.23
